Medically reviewed by Matthew Wosnitzer, MD Complement 3 glomerulopathy (C3G) is a rare kidney disease that is also ...

The US Food and Drug Administration (FDA) has granted Fast Track Designation to Complement Therapeutics’ CTx001, the ...

Complement Therapeutics GmbH (CTx), a clinical-stage biotechnology company developing next-generation therapeutics for complement-mediated diseases, today announced that the U.S. Food and Drug ...

From football fields to military training grounds, head injuries are leaving lasting marks on the brain in ways we're only ...

Businesses play a critical role in building a new, integrated system of learning and work because they see change first. They ...

US FDA grants fast track designation to Complement Therapeutics’ gene therapy candidate CTx001 to treat geographic atrophy: Munich Saturday, January 10, 2026, 17:00 Hrs [IST] Co ...

Medical University of South Carolina scientists have uncovered a link between the innate immune system and cognitive problems ...

A new study shows human immune systems differ across populations, raising new questions for medicine and global drug research ...

The 2025 KCSE results were released on Friday, January 9th, 2026. Out of 993,226 candidates, only 270,715- about 27%- ...

A rare but severe stem cell transplant complication that often becomes fatal now has its first FDA-approved treatment, a therapy developed by biotechnology company Omeros. The Christmas Eve regulatory ...

If you're living with IgA nephropathy (IgAN), you know the weight it carries—the constant worry about your kidneys, the fatigue from proteinuria, and the fear of progressing to dialysis or a ...